Non-ECMO | ECMO | p | |
---|---|---|---|
Age [years] | 69 (63; 71) | 61.5 (56; 65) | < 0.05 |
Body Mass Index [kg/m2] | 27.8 (25.1; 31.1) | 31 (26.2; 37.5) | 0.226 |
SOFA Score [points] | 11 (10;14) | 11 (10; 13) | 0.910 |
Charlson Comorbidity Index | 4 (3; 7) | 2 (2; 3) | < 0.05 |
Dosis of UFH [mg/h] | 1400 (800; 1800) | 1600 (1200; 1900) | 0.238 |
LMWH [mg/24 h] | 120 (100; 180) | - | - |
Horovitz Quotient at ICU admission * [mmHG] | 146 (114; 219) | 160 (137; 189) | 0.487 |
Lowest Horovitz Quotient during ICU stay * [mmHG] | 52 (45; 67.5) | 53 (37.5; 67.5) | 0.848 |
Prophylactic Anticoagulation | 9 (27%) | 3 (14%) | 0.195 |
Intermediate Anticoagulation | 11 (33%) | 15 (68%) | < 0.05 |
Any coagulation-associated Complication | 19 (58%) | 12 (55%) | 0.824 |
BARC_2 | 2 (6%) | 2 (9%) | 0.528 |
BARC_3c | 1 (3%) | 1 (5%) | 0.999 |
VTE/ATE at VET | 14 (42%) | 8 (36%) | 0.653 |
ATE | 2 (6%) | 0 | 0.356 |
DVT | 8 (24%) | 7 (32%) | 0.376 |
CAT | 0 | 2 (9%) | 0.156 |
PE | 11 (33%) | 6 (27%) | 0.634 |
In-hospital Death | 20 (61%) | 10 (45%) | 0.269 |